November 18, 2020
Pfizer’s, Biontech’s Covid-19 vaccine candidate meets endpints in P3 trial
Pfizer’s and Biontech’s vaccine candidate for COVID-19 has met all the study’s primary efficacy endpoints.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Coronavirus
July 1, 2020
Gilead Sciences’ top person, Daniel O’Day on 5-day treatment course with remdesivir for $2,340 per patient
Remdevisir has become a popular word these days, along with Covid-19, Coronavirus, the city of Wuhan, and for a good reason. The headline in all the news, the pricing of remdevisir, has been flooding the internet, and pretty much the TV.
June 3, 2020
Eurofins Technologies Launches Total Antibody (IgG, IgA and IgM) Detection ELISA Assays to Aid the Rapid Identification of Persons Who Have Been Exposed To SARS-CoV-2 (COVID-19)
Eurofins Technologies (Paris:ERF) announces the launch of a serology-based total antibody (IgG, IgA and IgM) detection ELISA assay for indirect diagnostic of past exposure to COVID-19.
June 3, 2020
FSD Pharma Receives U.S. FDA Approval to Design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis
FDA allowed FSD Pharma to submit an Investigational New Drug Application (IND) for the use of FSD-201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus.
June 2, 2020
CordenPharma, Moderna extend lipid supply agreement for Moderna’s coronavirus vaccine
CordenPharma has announced Tuesday its extended agreement with Moderna in its supply of lipids to support the development of Coronavirus Vaccine.
June 1, 2020
Coronavirus Vaccine Development Underway by Vault Pharma
Bioparticle-based delivery system offers potential as a coronavirus therapy LOS ANGELES–(BUSINESS WIRE)–An emerging company developing biotechnology invented at UCLA is…
May 26, 2020
Abivax announces German regulatory approval of ABX464 Covid-19 Phase 2b/3 COVID-19 clinical trial
Abivax said Monday that the German regulatory authority for drugs and medical products, BfArM (Bundesinstitut für Arnzeimittel und Medizinprodukte), has approved its Phase 2b/3 study of ABX464 in COVID-19 patients.
May 26, 2020
Nori Health offers free chatbot access for Crohn’s and Colitis patients during COVID-19 pandemic
the digital coach from Nori Health is made available for free from their website (use access code UKFREE) with the support of the Primary Care Society for Gastroenterology and its Chair, Dr Kevin Barrett.
May 22, 2020
Sinovac secures $15M for COVID-19 vaccine dvelopment
Advantech Capital and Vivo Capital have invested $15 million in Sinovac Research and Development Co., Ltd. (“Sinovac R&D”), a wholly owned subsidiary of Sinovac, to further the development of an inactivated vaccine against COVID-19 named CoronaVac.
May 21, 2020
Indica Labs, Octo and Axle work with NIH to launch a global COVID-19 digital pathology repository
Indica Labs and Octo have announced online COVID Digital Pathology Repository (COVID-DPR), a virtual collection of high resolution microscopic COVID-related human tissue images hosted at the National Institutes of Health.